Clinical trial Recruiting at 1 site Interventional Ages 20 and up

FAXAGE: Fasting and exercise to slow aging in older adults.

Official title: FAXAGE: A Randomized, Controlled Clinical Trial Of Fasting And Exercise To Slow Aging In Humans

Run by University of Copenhagen · NCT07207044 · Data updated 2026-11-12

This project will test whether time-restricted eating, exercise, or both can slow biological aging in people 65 and older.

Quick facts

Study typeInterventional
Ages20 Years and up
SexAll
Enrollment240 (estimated)
SponsorUniversity of Copenhagen
Academic / other
Locations1 site (Copenhagen, Copenhagen N)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedAugust 30, 2027
Study endsAugust 30, 2042
Registry record updatedJanuary 28, 2026
Trial IDNCT07207044 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 65 or older in generally good health (no more than one well-managed chronic disease), non-smokers who can commit to one year of time-restricted eating and/or supervised exercise and attend regular testing visits.

Probably not a fit

People with severe or uncontrolled medical conditions, current time-restricted eating habits, regular high-intensity exercise (>1 hour/week), active smoking, or use of systemic glucocorticoids or hormonal therapies are likely excluded or less likely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

FAXAge is a randomized, controlled one-year intervention enrolling 240 adults aged 65 and older who will be assigned to time-restricted feeding, supervised exercise, a combined intervention, or a control group. A reference cohort aged 20+ balanced by age and sex will be used to train algorithms for estimating biological age, while participants undergo repeated measures of physical, molecular, and digital biomarkers. Biomarkers include DNA-methylation, VO2max, body composition, and face- and voice-age, with measurements at baseline, 3 months, 6 months, and week 52. The primary outcome is DNA-methylation age at week 52 and secondary outcomes are the other biomarker changes and functional measures.

Why it matters

Potential benefit: If successful, the interventions could slow biological aging as measured by DNA-methylation and improve physical fitness and body composition in older adults.

How similar studies have gone: Prior studies have shown metabolic and functional benefits from intermittent fasting and exercise and some small studies report changes in epigenetic aging markers, but large randomized trials showing durable reductions in DNA-methylation age are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Provision of signed and dated informed consent
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Aged \>20 years
* In good general health meaning maximally 1 well-managed chronic disease
* Non-smoker.

Exclusion Criteria:

* Inability or unwillingness to adhere to the TRF regiment
* Inability or unwillingness to perform the prescribed physical exercise
* Treatment with other investigational drug or intervention within 1 year
* \>1 hour of systematic strenuous exercise or strength training a week
* Current time-restricted eating habits
* Severe or dysregulated medical disease (i.e. active cancer, uncontrolled diabetes, severe pulmonary or heart disease)
* \>1 well-managed chronic disease
* Smoker
* Use of systemic glucocorticoids, androgens or antiandrogens.

Where it's running

  • University of Copenhagen
    Copenhagen, Copenhagen N, Denmark
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.